Over 10 Nevada Auctions End Tomorrow 05/29 - Bid Now
Over 150 Total Lots Up For Auction at One Location - CA 06/06

AtomVie Global Radiopharma Inc. announces its spinout and Series A financing with Avego

Press releases may be edited for formatting or style | August 24, 2022 Business Affairs Molecular Imaging

With its world-class employees and its in-depth experience in the radiopharmaceutical industry, AtomVie empowers the development of next-generation radiotherapeutics worldwide.


About AtomVie Global Radiopharma Inc. ("AtomVie"):
stats
DOTmed text ad

We repair MRI Coils, RF amplifiers, Gradient Amplifiers and Injectors.

MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013

stats

AtomVie, incorporated in late 2021, is a global leading CDMO for the GMP manufacturing and distribution of clinical and commercial radiopharmaceuticals and figures as the most recent spinout from the CPDC. Founded in 2008, the CPDC is a CECR (Centre of Excellence for Commercialization and Research) located at McMaster University in Hamilton, Ontario, Canada. The CPDC was created with the long-time support from the NCE (Networks of Centres of Excellence), McMaster University and the OICR (Ontario Institute for Cancer Research). The expertise developed at the CPDC and its position as a global leading CDMO is the stepping stone for AtomVie spinout.


About Avego Management, LLC ("Avego"):
Avego, founded in 2015 by former healthcare entrepreneurs, is a multi-strategy healthcare-focused investment firm with offices in Georgia and New York. Through its three strategies, which include private equity, venture capital, and a hedge fund, Avego invests in private and public companies developing and commercializing innovative products and services for patients, practitioners, and other stakeholders across the healthcare continuum.


SOURCE AtomVie Global Radiopharma Inc.

Back to HCB News

You Must Be Logged In To Post A Comment